GSK starts big African study of injectable drug to prevent HIV
(Reuters) - ViiV Healthcare, GlaxoSmithKline Plc's HIV unit, said on Thursday it started an African study to evaluate long-acting injectable drug for the prevention of HIV infection in sexually active women.
from RSSMix.com Mix ID 8260657 http://ift.tt/2AoafZp
from RSSMix.com Mix ID 8260657 http://ift.tt/2AoafZp
Comments
Post a Comment